Plasma Concentration of Suppressor of Tumorigenicity 2...

Biology of Blood and Marrow Transplantation 2012 Vol. 18; Iss. 2-supp-S

Plasma Concentration of Suppressor of Tumorigenicity 2 (ST2), the IL33 Receptor, at Initiation of Graft Versus Host Disease Therapy Predicts Day 28 Response and Day 180 Survival Post-Treatment

M.T. Vander Lugt, T. Braun, J.L.M. Ferrara, S. Hanash, J.E. Levine, C.-H. Wang, Q. Zhang, Q. Zhang, A. Chin, A. Harris, S.W.J. Choi, D. Couriel, P. Reddy, S. Paczesny
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
18
Year:
2012
Language:
english
Pages:
1
DOI:
10.1016/j.bbmt.2011.12.525
File:
PDF, 87 KB
english, 2012
Conversion to is in progress
Conversion to is failed